Cryopreservation is the process of freezing tissues and cells at low temperatures to keep the biological material metabolically inert, maintain its viability, and prevent ice crystal formation. Cells are cryopreserved to minimize genetic change and prevent loss through contamination. The equipment which is designed to preserve the biological material is known as cryopreservation equipment. Cryopreservation is primarily used for the preservation of oocytes and embryos with in-vitro fertilization (IVF) cycle and before chemotherapy for women diagnosed with breast cancer, to preserve their reproductive capacity. Moreover, it is also used for the preservation of sperms, plant seeds, and other biological materials used for research purposes in the future. The cryopreservation process involves solutions for cryopreservation which include a high concentration of cryoprotective agents. These cryoprotective agents provide improved osmotic balance and dehydration during cooling.
COVID-19 Impact Analysis
- COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
- There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the cryopreservation equipment market.
Top Impacting Factors
Increase in demand for regenerative medicines, and advancements in the biobanking technology are expected to boost the market growth.
In addition, surge in demand for fertility treatments such as In Vitro Fertilization (IVF) treatment and therapies, for women and higher effectiveness of frozen embryos in the IVF procedures act as major growth drivers for the cryopreservation equipment market.
Increase in clinical and research studies in stem cell applications using cryopreservation equipment boosts the growth of the market during the forecast period.
Moreover, surge in demand for self-storage of cord blood stem cells, and increase in number of government initiatives to raise awareness about preservation of stem cells are other major factors that are expected to propel the market growth.
Technological advancements, increase in research in medical and pharmaceutical studies, and rise in healthcare expenditure fuel the market growth.
However, stability issues and storage problems are factors anticipated to restrain the growth of the market.
Market Trends
New Product Launches to Flourish the Market
- In January 2019, Royal Free Hospital in London launched a new ovarian tissue freezing program, designed to help women and girls about to be treated for cancer to preserve their fertility.
- In January 2019, cryopreservation company Acorn Biolabs closed seed funding and ramps towards consumer launch.
- In January 2018, Linde LLC introduced its new CRYOLINE CWI CRYOWAVE impingement freezer. The new product combines the benefits of CRYOWAVE product agitation with cryogenic gas impingement flows, which utilizes liquid nitrogen to freeze products.
Key Benefits of the Report
- This study presents the analytical depiction of the cryopreservation equipment market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the cryopreservation equipment market share.
- The current market is quantitatively analyzed to highlight the cryopreservation equipment market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Cryopreservation Equipment Market Report
- Which are the leading market players active in the cryopreservation equipment market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is cryopreservation equipment market?
- What is cryopreservation equipment market prediction in the future?
- Who are the leading global players in the cryopreservation equipment market?
- What are the current trends and predicted trends?
- What are the key benefits of the cryopreservation equipment market report?
Cryopreservation Equipment Market Report Highlights
| Aspects | Details |
 By Equipment |
|
 By Cryogen |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Merck KGaA, Nikkiso Cryo Inc., Chart Biomedical Co. Ltd., Linde LLC, Barber-Nichols Inc., Charter Medicals, Cryogenic Control,, Planer PLC, Custom Biogenic Systems, Haimen United Laboratory Equipment Development Co., Ltd., Praxair Technology Inc., Thermo Fisher Scientific Inc., Cryologic Pty. Ltd. |
Loading Table Of Content...
